Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2011 Feb 26;252(3):250–258. doi: 10.1016/j.taap.2011.02.016

Table 1.

Compounds used in the confirmation and follow-up studies

Compound CASRN Purity (%)
1,3-diphenylguanidine 102-06-7 99.5
2-aminoanthracene 613-13-8 96
3,3,5-trimethylcyclohexyl salicylate 118-56-9 NP
4′-N-hexyl-4-biphenylcarbonitrile 41122-70-7 98
astemizole 68844-77-9 98
benzethonium chloride 121-54-0 99
benzyltrimethylammonium chloride 56-93-9 97
cetyltrimethylammonium bromide 57-09-0 100
curcumin 458-37-7 80
D&C red dye 27 18472-87-2 NP
decamethonium bromide 541-22-0 99
didecyl dimethyl ammonium chloride 2390-68-3 98
digitonin 11024-24-1 63
domiphen bromide 538-71-6 97
econazole nitrate 24169-02-6 99
malachite green oxalate 2437-29-8 NP
o,p′-DDT 789-02-6 NP
quinidine 56-54-2 89
reserpine 50-55-5 98
tamoxifen, citrate salt 54965-24-1 99
tetra-n-octylammonium bromide 14866-33-2 98
tricresyl phosphate 1330-78-5 90
trixylenyl phosphate 25653-16-1 90
verapamil 152-11-4 99
zinc pyrithione 13463-41-7 95

Abbreviations: CASRN = Chemical Abstracts Services Registry Number; DDT = 1,1,1-trichloro-2-(2-chlorophenyl)-2-(4-chlorophenyl)ethane; NP = not provided by vendors